These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 11532942

  • 1. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M.
    EMBO J; 2001 Sep 03; 20(17):4782-93. PubMed ID: 11532942
    [Abstract] [Full Text] [Related]

  • 2. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.
    Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911
    [Abstract] [Full Text] [Related]

  • 3. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion.
    Sato T, Sawaji Y, Matsui N, Sato H, Seiki M, Mori Y, Ito A.
    Biochem Biophys Res Commun; 1999 Nov 15; 265(1):189-93. PubMed ID: 10548512
    [Abstract] [Full Text] [Related]

  • 4. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
    Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y.
    Cancer Res; 1996 Jun 15; 56(12):2707-10. PubMed ID: 8665498
    [Abstract] [Full Text] [Related]

  • 5. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
    Luo XH, Liao EY.
    Horm Metab Res; 2001 Jul 15; 33(7):383-8. PubMed ID: 11507673
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 8. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells.
    Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW, Strongin AY.
    Exp Cell Res; 2001 Feb 15; 263(2):209-23. PubMed ID: 11161720
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
    Sato T, Iwai M, Sakai T, Sato H, Seiki M, Mori Y, Ito A.
    Br J Cancer; 1999 Jun 15; 80(8):1137-43. PubMed ID: 10376963
    [Abstract] [Full Text] [Related]

  • 10. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S, Lehti K, Keski-Oja J, Mignatti P.
    J Cell Physiol; 2002 Aug 15; 192(2):160-70. PubMed ID: 12115722
    [Abstract] [Full Text] [Related]

  • 11. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP.
    Hernandez-Barrantes S, Shimura Y, Soloway PD, Sang QA, Fridman R.
    Biochem Biophys Res Commun; 2001 Feb 16; 281(1):126-30. PubMed ID: 11178970
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors.
    Ueda J, Kajita M, Suenaga N, Fujii K, Seiki M.
    Oncogene; 2003 Nov 27; 22(54):8716-22. PubMed ID: 14647466
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
    Li H, Bauzon DE, Xu X, Tschesche H, Cao J, Sang QA.
    Mol Carcinog; 1998 Jun 27; 22(2):84-94. PubMed ID: 9655252
    [Abstract] [Full Text] [Related]

  • 17. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
    Kayano K, Shimada T, Shinomiya T, Nakai S, Hisa Y, Aoki T, Seiki M, Okada Y.
    J Pathol; 2004 Apr 27; 202(4):403-11. PubMed ID: 15095267
    [Abstract] [Full Text] [Related]

  • 18. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
    Gilles C, Bassuk JA, Pulyaeva H, Sage EH, Foidart JM, Thompson EW.
    Cancer Res; 1998 Dec 01; 58(23):5529-36. PubMed ID: 9850090
    [Abstract] [Full Text] [Related]

  • 19. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y.
    Cancer Res; 1997 May 15; 57(10):2055-60. PubMed ID: 9158005
    [Abstract] [Full Text] [Related]

  • 20. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K.
    EMBO J; 1998 Sep 01; 17(17):5238-48. PubMed ID: 9724659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.